ANURAS Anupam Rasayan India Q2 FY26 results (Jul–Sep 2025) and concall
Anupam Rasayan announced the strategic acquisition of Jayhawk Fine Chemicals for USD150 million, significantly enhancing its global presence with direct US manufacturing capabilities. This move is expected to be EPS-accretive from day one, leveraging Jayhawk's USD78 million CY24 revenue and ~19% EBITDA margins to create a pro-forma entity with USD243 million revenue and USD61 million EBITDA. The acquisition aligns with Anupam's strategy to build an integrated specialty and CDMO platform, expanding into high-value end markets and strengthening customer relationships.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q2 FY26: revenue up 148.6%, net profit up 83.9% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|
| Revenue | 294 | 390 | 500 | 486 | 731 +149% |
| EBITDA | 80 | 124 | 144 | 124 | 136 +70% |
| Net profit | 31 | 54 | 63 | 48 | 57 +84% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
